Bactrim (Trimethoprim-Sulfamethoxazole) Dosing for Skin Infections
For skin infections, the recommended dosage of Bactrim (trimethoprim-sulfamethoxazole) is 1-2 double-strength tablets (160mg/800mg) twice daily for adults. 1
Adult Dosing Recommendations
Uncomplicated Skin and Soft Tissue Infections (SSTIs)
- Standard dose: 1-2 double-strength tablets (160mg/800mg) twice daily orally 1
- Duration: Typically 7 days, depending on clinical response 1
- Efficacy note: Bactericidal against many common skin pathogens, including MRSA
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
- Same dosing as above: 1-2 double-strength tablets twice daily orally 1
- Higher doses (320mg/1600mg twice daily) have not shown superior efficacy compared to standard dosing for MRSA skin infections 2
Pediatric Dosing Recommendations
- Standard dose: 8-12 mg/kg/day (based on trimethoprim component) in 2 divided doses orally 1
- Maximum dose: Should not exceed adult dosing
- Note: Not recommended for infants younger than 2 months 1
Clinical Considerations
Advantages of Bactrim for Skin Infections
- Good tissue penetration: Studies show excellent penetration into skin with a ratio of 0.94 ± 0.23 for trimethoprim and 0.82 ± 0.21 for sulfamethoxazole between skin blister fluid and plasma 3
- Effective against MRSA: Particularly important in areas with high community-acquired MRSA prevalence
- Cost-effective: Generally less expensive than newer agents
Limitations and Cautions
- Resistance concerns: Local resistance patterns should be considered
- Contraindications:
- Pregnancy at term
- Nursing mothers
- Infants less than 2 months of age
- Patients with marked hepatic damage or severe renal insufficiency
- Known hypersensitivity to trimethoprim or sulfonamides
Monitoring
- Monitor for adverse effects including:
- Rash (most common)
- GI upset
- Hyperkalemia (particularly in elderly or those on other potassium-sparing medications)
- Bone marrow suppression (rare but serious)
Special Populations
Renal Impairment
- Dose adjustment required for creatinine clearance <30 mL/min
- For severe renal impairment, consider monitoring drug levels 4
Elderly
- May require lower doses due to decreased renal function
- Higher risk of adverse effects, particularly hyperkalemia and bone marrow suppression
Treatment Algorithm
Assess infection severity:
- Uncomplicated: No systemic symptoms, limited area
- Complicated: Extensive, systemic symptoms, immunocompromised host
For uncomplicated infections:
- Start with 1 double-strength tablet twice daily
- Consider incision and drainage if abscess present
For complicated infections or extensive disease:
- Consider 2 double-strength tablets twice daily
- Evaluate need for initial IV therapy before oral switch
Reassess in 48-72 hours:
- If improving: Complete 7-day course
- If not improving: Reevaluate diagnosis, consider culture, alternative antibiotics
Common Pitfalls to Avoid
- Underdosing: Using single-strength tablets instead of double-strength for skin infections
- Inadequate duration: Treating for less than 7 days may lead to treatment failure
- Ignoring local resistance patterns: In areas with TMP-SMX resistance >20%, consider alternative agents
- Missing underlying abscesses: Failure to drain purulent collections when present will lead to treatment failure regardless of antibiotic choice
Bactrim remains a highly effective option for skin infections, particularly those caused by community-acquired MRSA, when used at appropriate doses and durations.